SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALLOCCHIO, Franco Pasquale Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.789
AS - Asia 8.293
EU - Europa 4.222
SA - Sud America 1.296
AF - Africa 192
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 14
Totale 27.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.537
SG - Singapore 3.014
CN - Cina 2.316
BR - Brasile 1.007
UA - Ucraina 919
VN - Vietnam 900
DE - Germania 809
HK - Hong Kong 638
TR - Turchia 552
IT - Italia 464
GB - Regno Unito 461
FI - Finlandia 359
FR - Francia 254
RU - Federazione Russa 247
JP - Giappone 236
SE - Svezia 230
IN - India 167
PL - Polonia 159
MX - Messico 112
CA - Canada 108
AR - Argentina 93
BD - Bangladesh 84
ZA - Sudafrica 64
ID - Indonesia 56
IQ - Iraq 51
NL - Olanda 47
ES - Italia 43
CO - Colombia 42
EE - Estonia 37
PK - Pakistan 37
EC - Ecuador 36
VE - Venezuela 35
CZ - Repubblica Ceca 33
PH - Filippine 30
BE - Belgio 29
MY - Malesia 28
MA - Marocco 27
UZ - Uzbekistan 27
CL - Cile 26
LT - Lituania 24
PY - Paraguay 22
SA - Arabia Saudita 21
AT - Austria 17
IR - Iran 16
TN - Tunisia 16
ET - Etiopia 15
EG - Egitto 14
AU - Australia 12
KE - Kenya 12
AZ - Azerbaigian 11
BO - Bolivia 11
DZ - Algeria 11
IE - Irlanda 11
PE - Perù 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
EU - Europa 9
IL - Israele 9
RO - Romania 9
SD - Sudan 9
KR - Corea 8
LB - Libano 8
NP - Nepal 8
OM - Oman 8
AL - Albania 7
CH - Svizzera 7
JM - Giamaica 7
JO - Giordania 7
PT - Portogallo 7
AO - Angola 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
GE - Georgia 5
KZ - Kazakistan 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
BY - Bielorussia 4
DK - Danimarca 4
HN - Honduras 4
KG - Kirghizistan 4
KW - Kuwait 4
MT - Malta 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
BH - Bahrain 3
CY - Cipro 3
GR - Grecia 3
MD - Moldavia 3
MK - Macedonia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
BB - Barbados 2
Totale 27.792
Salva come PNG Salva come JPEG
Città #
Singapore 1.946
Woodbridge 1.295
Ashburn 1.245
Jacksonville 1.002
Chandler 962
Fairfield 893
Houston 791
San Jose 785
Santa Clara 668
Beijing 661
Hong Kong 619
Ann Arbor 570
Wilmington 400
Dallas 318
Izmir 305
Seattle 293
Nanjing 287
Ho Chi Minh City 279
Cambridge 263
Tokyo 227
Princeton 209
Hanoi 204
Los Angeles 204
Munich 180
Dearborn 168
Boardman 166
Lauterbourg 158
Warsaw 149
New York 130
Ferrara 124
Shenyang 108
Nanchang 105
Helsinki 103
San Diego 99
São Paulo 97
Shanghai 85
Tianjin 82
Milan 78
Changsha 73
Turku 62
Addison 61
Mexico City 61
Hebei 59
Hefei 54
Orem 54
Buffalo 53
Da Nang 51
London 50
Bremen 49
Jiaxing 47
Chennai 46
Frankfurt am Main 41
Montreal 40
Brooklyn 38
Mountain View 38
Moscow 37
Stockholm 37
Haiphong 36
Chicago 35
Guangzhou 34
Jinan 34
Ningbo 34
Redwood City 33
Toronto 33
San Francisco 32
Poplar 31
Denver 30
Orange 30
Kunming 29
Phoenix 29
Atlanta 28
Manchester 28
Norwalk 27
San Mateo 27
Brno 26
Brussels 26
Bologna 25
Biên Hòa 24
Zhengzhou 24
Amsterdam 23
Boston 23
Düsseldorf 23
Johannesburg 23
Tashkent 23
Rio de Janeiro 22
The Dalles 22
Washington 21
Baghdad 20
Council Bluffs 20
Curitiba 20
Mumbai 20
Auburn Hills 19
Leawood 18
Augusta 16
Falkenstein 16
Ninh Bình 16
Belo Horizonte 15
Falls Church 15
Jakarta 15
Vienna 15
Totale 18.269
Salva come PNG Salva come JPEG
Nome #
Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase 297
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 271
6-Phosphogluconate dehydrogenase from Trypanosoma brucei - Kinetic analysis and inhibition by trypanocidal drugs 247
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 245
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 238
Differentiation between the structural and redox roles of TPNH in 6-phosphogluconate dehydrogenase 230
6-phosphogluconate dehydrogenase: structural symmetry and functional asymmetry 228
A role for the pyridine nitrogen of reduced triphosphopyridine-nucleotide in the mechanism of action of isocitrate dehydrogenase 225
Role of Methionine 13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 224
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 224
A rapid method for purification of myelin basic protein 220
A new powerful inhibitor specific for the TPN binding site of 6-phosphogluconate dehydrogenase 213
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 210
Inhibitors of Trypanosoma brucei 6-phosphogluconate dehydrogenase 209
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies 208
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 205
A role for the pyridine nitrogen of reduced triphosphopyridinenucleotide in an enzymatic catalysis 204
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 203
Activation of the sendai virus fusion protein by receptor binding 200
6-Phosphogluconate dehydrogenase mechanism: Evidence for allosteric modulation by substrate 200
Activation of the Sendai virus fusion protein by receptor binding 199
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 198
Identification of the chemical groups involved in the binding of periodate-oxidized NADP+ to 6-phosphogluconate dehydrogenase. 197
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 193
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 190
Isotope effect as a probe of the catalytic rilevance of coenzyme isomerization in the enzyme 6-phosphogluconate dehydrogenase from sheep liver 189
Mutual communication of envelope glycoproteins of paramixoviruses 188
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 186
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 186
6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomiasis 184
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 183
Proper orientation of the nicotinamide ring of NADP is important for the precatalytic conformational change in the 6-phosphogluconate dehydrogenase reaction 183
Analisi della proteina basica della mielina nel liquor 183
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 183
Surface mapping of Env protein from HIV by chemical modifications 182
6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species 182
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 180
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 178
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 177
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 174
Substrate binding to 6-phosphogluconate dehydrogenase 173
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 172
X-ray escaping conformational changes affecting enzymatic function 172
Role of methionine-13 in the catalytic mechanism of 6-phosphogluconate dehydrogenase from sheep liver 169
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
X-ray escaping conformational changes affecting enzymatic function 168
A new hypothesis on the mechanism of action of lamb liver 6-phosphogluconate dehydrogenase 168
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 168
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 167
Bromopyruvate for the affinity labelling of a single cysteine residue near the carboxylate binding site of lamb liver 6-phosphogluconate dehydrogenase 167
"Do the two subunits of lamb liver 6-phosphogluconate dehydrogenase alternate their role during catalysis?" 166
Biochemical study in adult population with stroke in Ferrara, Fabry disease 166
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 165
A multiple role for the coenzyme in the mechanism of action of 6-phosphogluconate dehydrogenase 164
A further non-redox role for NADPH in the mechanism of action of 6-pho-sphogluconate dehydrogenase from lamb liver 162
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 162
A catalytic tyrosine at the active site of sendai virus neuraminidase 161
NADPH activates a decarboxylation reaction catalysed by lamb liver 6-phosphogluconate dehydrogenase 161
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 160
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 160
Isothermal titration calorimetry tool to better characterize the mechanism of T. brucei 6-phosphogluconate dehydrogenase 158
Anomeric specificity of the neuraminidase from sendai virus 158
Alternating site catalytic cooperativity in some 6-phosphogluconate dehydrogenases 158
Thermodynamic characterization by ITC and DSC of the binding of 4-phospho-d-erythronate to the target enzyme T. brucei 6-phosphogluconate dehydrogenase 156
Evidences for the proximity of two sulfhydryl groups in the active site of 6-phosphogluconate dehydrogenase 156
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 155
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 155
Evidence for multiple pairs of vicinal thiols in some proteins 154
Alkylation of 6-phosphogluconate dehydrogenase from Candida utilis with coenzyme analogues 154
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 153
Use of Trinitrobenzensulfonate for Affinity Labeling of Lysine Residues at Phosphate Binding Sites of Some Enzymes 153
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 152
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 151
Energy cost for the proper ionization of active site residues in 6-phosphogluconate dehydrogenase from T. brucei 151
Pharmacological potential of inhibitors of 6-phosphogluconate dehydrogenase from T.brucei: differentiation of substrate analogues from reaction-intermediate analogues by isothermal titration calorimetry 150
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 150
Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma Brucei 149
Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase 149
The mechanism of 6PGDH investigated by kinetics isotope effects 149
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 148
Evidence for the proximity of a cysteinyl and a tyrosyl residue in the active sita of 6-phosphogluconate dehydrogenase 148
Is there an alternating site co-operativity between the two subunits of lamb liver 6-phosphogluconate dehydrogenase? 148
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 147
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 147
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 147
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 147
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 147
Cysteine 365 may have a role in the catalytic mechanism of 6-Phosphogluconate Dehydrogenase from Sheep Liver 144
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 143
Dynamics of phosphorus in the Venice lagoon during a picocyanobacteria bloom 142
Domain structure of the hemagglutinin-neuraminidase from sendai virus 142
Features of hypereutrophic Molino lagoon ecosystem dominated by sedentary polychaetes 141
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 141
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 140
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 138
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 138
Purification of transglutaminase enzyme from L. infantum promastigotes 137
Biochemical characterization of the natural Cys386-FX variant: a new tool to investigate coagulation factor X functions? 136
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 135
Totale 17.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 627
Totale 120.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021660 0 0 0 0 0 0 0 0 0 247 332 81
2021/20221.751 33 189 85 68 96 71 36 84 51 177 180 681
2022/20232.055 210 156 54 244 379 290 64 208 251 18 114 67
2023/2024843 93 123 48 30 81 120 16 60 15 15 21 221
2024/20253.743 101 80 335 147 496 266 146 202 542 471 531 426
2025/20269.967 1.047 513 1.005 1.401 1.538 679 1.154 525 1.093 1.012 0 0
Totale 28.022